Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
Xiudong GuanLanxin LuoGulnaz BegumGary KohanbashQingkun SongAparna RaoNduka AmankulorBaoshan SunDandan SunWang JiaPublished in: Journal of experimental & clinical cancer research : CR (2018)
Our findings strongly suggest that NHE1 protein emerges as a marker for tumorigenesis and prognosis in glioma. Blocking NHE1 protein is a novel strategy for adjuvant anti-cancer therapies.